Atazanavir for the treatment of human immunodeficiency virus infection

Medicine & Life Sciences

• Atazanavir Sulfate 100%
• Virus Diseases 49%
• HIV 46%
• Protease Inhibitors 42%
• Tenofovir 13%
• Hyperbilirubinemia 12%
• Highly Active Antiretroviral Therapy 11%
• Therapeutics 11%
• Hypericum 7%
• efavirenz 6%
• Lovastatin 6%
• Histamine Receptors 6%
• Cytochrome P-450 CYP2C9 6%
• Glucuronosyltransferase 6%
• Antacids 6%
• Uridine Diphosphate 6%
• Ritonavir 6%
• Diltiazem 6%
• Simvastatin 6%
• Irinotecan 6%
• Cytochrome P-450 CYP3A 5%
• Proton Pump Inhibitors 5%
• Warfarin 5%
• Peripheral Nervous System Diseases 5%
• Exanthema 5%
• Drug Interactions 5%
• Cytochrome P-450 Enzyme System 5%
• Drug-Related Side Effects and Adverse Reactions 4%
• Abdominal Pain 4%
• Nausea 4%
• In Vitro Techniques 4%
• HIV-1 4%
• Vomiting 4%
• Headache 4%
• Diarrhea 4%
• Lipids 3%
• Infections 2%